RASA1 and breast cancer: In addition, DOK2 deficiency in ovarian cancer induced carboplatin resistance by inhibiting the apoptosis of tumor cells [38], while the expression of DOK2/Ras p21 protein activator 1 was associated with prognosis and quality of life of breast cancer patients.